Q3 2023 · 13F-HR
COURAGE CAPITAL MANAGEMENT LLCholdings as filed
Filed 2023-11-08 · accession 0001567619-23-007662
$29,484
Reported value
12
Positions
2023-09-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 19249HAB9 | — | Coherus Biosciences Inc | $11,025 | 37.4% | 18,000,000 | Common | SOLE |
| 85207H104 | PHYS | Sprott Physical Gold Trust | $3,788 | 12.8% | 264,500 | Common | SOLE |
| 30050BAD3 | EVH 1.5 10/15/25 | Coherus Biosciences Inc | $3,668 | 12.4% | 3,434,000 | Common | SOLE |
| 38150K103 | AAAU | Goldman Sachs Physical Gold | $3,374 | 11.4% | 184,254 | Common | SOLE |
| 30303M102 | META | Humana Inc | $2,402 | 8.15% | 8,000 | Common | SOLE |
| 444859102 | HUM | Humana Inc | $1,654 | 5.61% | 3,400 | Common | SOLE |
| 22822V101 | CCI | Crown Castle Intl | $1,104 | 3.74% | 12,000 | Common | SOLE |
| 464285204 | IAU | Johnson & Johnson Inc | $980 | 3.32% | 28,000 | Common | SOLE |
| 02079K107 | GOOG | Alphabet Inc Class C | $725 | 2.46% | 5,500 | Common | SOLE |
| 478160104 | JNJ | Matinas Biopharma Holdings Inc | $312 | 1.06% | 2,000 | Common | SOLE |
| 369550108 | GD | General Dynamics Corp | $265 | 0.90% | 1,200 | Common | SOLE |
| 19249H103 | CHRS | Coherus Biosciences Inc | $187 | 0.63% | 50,000 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.